![GlycoMimetics Inc](/common/images/company/N_GLYC.png)
GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1581 | 60.412686282 | 0.2617 | 0.4998 | 0.25 | 310177 | 0.27537948 | CS |
4 | 0.1668 | 65.9288537549 | 0.253 | 0.4998 | 0.2426 | 280705 | 0.27348613 | CS |
12 | 0.0744 | 21.5402431963 | 0.3454 | 0.4998 | 0.1912 | 624244 | 0.27556703 | CS |
26 | 0.2388 | 131.933701657 | 0.181 | 0.63 | 0.1406 | 10307508 | 0.46802511 | CS |
52 | -2.6902 | -86.501607717 | 3.11 | 3.36 | 0.1406 | 6444600 | 0.47323187 | CS |
156 | -0.6502 | -60.7663551402 | 1.07 | 4.16 | 0.1406 | 2400443 | 0.64020559 | CS |
260 | -3.8202 | -90.0990566038 | 4.24 | 5.75 | 0.1406 | 1659552 | 0.95771321 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.